- Home
- HHS vs XCUR Comparison
HHS vs XCUR Comparison
Compare HHS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- XCUR
- Stock Information
- Founded
- HHS 1923
- XCUR 2011
- Country
- HHS United States
- XCUR United States
- Employees
- HHS N/A
- XCUR N/A
- Industry
- HHS Advertising
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- HHS Consumer Discretionary
- XCUR Health Care
- Exchange
- HHS Nasdaq
- XCUR Nasdaq
- Market Cap
- HHS 37.4M
- XCUR 43.6M
- IPO Year
- HHS N/A
- XCUR N/A
- Fundamental
- Price
- HHS $5.19
- XCUR $10.07
- Analyst Decision
- HHS
- XCUR
- Analyst Count
- HHS 0
- XCUR 0
- Target Price
- HHS N/A
- XCUR N/A
- AVG Volume (30 Days)
- HHS 24.8K
- XCUR 110.7K
- Earning Date
- HHS 03-13-2025
- XCUR 11-14-2024
- Dividend Yield
- HHS N/A
- XCUR N/A
- EPS Growth
- HHS N/A
- XCUR N/A
- EPS
- HHS N/A
- XCUR N/A
- Revenue
- HHS $187,604,000.00
- XCUR $500,000.00
- Revenue This Year
- HHS N/A
- XCUR N/A
- Revenue Next Year
- HHS $4.05
- XCUR N/A
- P/E Ratio
- HHS N/A
- XCUR N/A
- Revenue Growth
- HHS N/A
- XCUR N/A
- 52 Week Low
- HHS $4.85
- XCUR $1.44
- 52 Week High
- HHS $8.87
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- HHS 42.75
- XCUR 42.53
- Support Level
- HHS $5.04
- XCUR $8.51
- Resistance Level
- HHS $5.20
- XCUR $11.37
- Average True Range (ATR)
- HHS 0.26
- XCUR 1.88
- MACD
- HHS 0.02
- XCUR -0.61
- Stochastic Oscillator
- HHS 45.95
- XCUR 22.09
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.